Sapelizumab (Anti-IL-6Ra / CD126)

Sapelizumab (Anti-IL-6Ra / CD126) is a human monoclonal antibody targeting IL-6. It is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. MW :144.26 KD.
Supplier Selleck Chemicals
Product # A2984
Sku # A2984-1mg*25
Pricing 1mg*25, $5970.00
Feedback